Physician profile
Katie Dougherty
NPI 1962433649
$612.28
in general payments reported to CMS, 2019-2025
6 companies · $80.93 in 2025
The $80.93 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $175 · 2021: $163 · 2022: $18.64 · 2023: $139 · 2024: $34.98 · 2025: $80.93.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $255.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $254.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $285.72 | 2021-2025 | Vraylar |
| Amarin Pharma, INC. | $145.99 | 2020-2021 | |
| Allergan, INC. | $83.01 | 2020 | |
| Lilly USA, LLC | $60.44 | 2024-2025 | Mounjaro |
| Idorsia Pharmaceuticals US INC | $20.61 | 2023 | Quviviq |
| Janssen Pharmaceuticals, INC | $16.51 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katie Dougherty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.